Skip to main content

University of Maryland School of Medicine Completed Phase One of Clinical Trial for Pfizer COVID-19 Vaccine

Did you know? Greater Baltimore’s University of Maryland School of Medicine Official Page completed phase one of the clinical trial for pharmaceutical company Pfizer’s COVID-19 vaccine candidate earlier this spring. Reported by WBAL-TV 11 Baltimore, the Pfizer vaccine that got its start in Baltimore has been proven to be 90% effective in early results. UMSOM will also be involved in running the phase three COVID-19 vaccine trial for biotech company Moderna, with results due later this year. Learn about the Region’s strength in the life sciences industry in EAGB’s Life Science Industry Profile:

Read More

Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927